Submitted by Anonymous (not verified) on 4 September 2024 - 11:15
Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Date of authorisation: 03/08/2001, Revision: 37, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Date of authorisation: 03/08/2001, Revision: 37, Status: Authorised